Tag: vaccine
Covid: as the Eris variant progresses, a new vaccine will be available from the end of September
The Eris variant has been increasingly present for several weeks. Faced with the rise of Eris, a new variant of Covid-19 of the Omicron type, an unprecedented vaccine will arrive…
Another vaccine candidate against malaria targets the erythrocyte phase
Phase Ib study Due to the complexity of malaria infection, the combination of two vaccination approaches is considered to be the most promising strategy. On the…
Vaccine against multiple sclerosis in sight – Pressetext.com
Multiple sclerosis vaccine on the horizon Pressetext.com Multiple sclerosis and herpes: study proves connection with EBV 24vita.de Vaccine candidate targets lymph nodes Pharmaceutical Newspaper Epstein-Barr virus: New vaccine successfully tested on mice PICTURE Vaccine…
Biontech Posts Loss in Second Quarter – Economy
The corona boom came to an abrupt end at the biotech company Biontech. In the second quarter, Biontech posted a net loss of a good 190 million euros after a…
BioNTech: New vaccine in September, second quarter loss
Status: 07.08.2023 2:06 p.m BioNTech experiences the end of the Corona boom and records a loss of 190.4 million euros in the second quarter. In the previous year there was…
Biontech makes a loss – economy
The corona boom came to an abrupt end at the biotech company Biontech. In the second quarter, Biontech posted a net loss of a good 190 million euros after a…
After the cardiac arrest of Bronny James, Elon Musk and the antivaxers hasten to accuse the anti-Covid vaccine
At this stage, it is unknown what caused Bronny James’ cardiac arrest. The son of LeBron James, who collapsed while training in Los Angeles with his USC team on Monday,…
A vaccine for infants and the elderly approved by the European regulator
The European regulator on Friday authorized a first vaccine intended to protect both infants and people aged 60 and over against the respiratory virus RSV, known especially for the scourge…
A vaccine for infants and the elderly approved by the European regulator
The European regulator on Friday authorized a first vaccine intended to protect both infants and people aged 60 and over against the RSV respiratory virus, known above all for the…
First RSV vaccine for babies about to be approved – knowledge
The first vaccine for infants against the so-called respiratory syncytial virus (RSV) could soon be on the market in the EU. The responsible committee of the drug authority EMA recommended…